EMFO LLC’s TG Therapeutics TGTX Stock Holding History

EMFO LLC’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$205K	Hold	11,500	–	–	0.18%	90
2024 Q1	$175K	Hold	11,500	–	–	0.16%	101
2023 Q4	$196K	Hold	11,500	–	–	0.18%	92
2023 Q3	$96.1K	Hold	11,500	–	–	0.09%	123
2023 Q2	$286K	Hold	11,500	–	–	0.26%	73
2023 Q1	$173K	Hold	11,500	–	–	0.16%	96
2022 Q4	$136K	Sell	11,500 -2,000	-15%	-$14.5K	0.14%	106
2022 Q3	$80K	Hold	13,500	–	–	0.08%	149
2022 Q2	$57K	Sell	13,500 -1,000	-7%	-$6.24K	0.06%	175
2022 Q1	$138K	Hold	14,500	–	–	0.13%	129
2021 Q4	$276K	Hold	14,500	–	–	0.24%	87
2021 Q3	$483K	Hold	14,500	–	–	0.43%	54
2021 Q2	$562K	Buy	+14,500	New	+$569K	0.49%	49

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EMFO LLC's TGTX Position: Q2 2024 in Review

EMFO LLC held its TG Therapeutics (TGTX) position steady in Q2 2024 at 11,500 shares worth $205K. The position accounts for 0.18% of the portfolio, ranked #90.

EMFO LLC first reported a position in TGTX in Q2 2021 and has held it in 13 quarters since. The position peaked at $562K in Q2 2021. 259 funds tracked by Wall St. Rank hold TGTX as of Q2 2024.

EMFO LLC held 11,500 shares of TG Therapeutics worth $205K as of Q2 2024.
EMFO LLC left its TG Therapeutics share count unchanged in Q2 2024.
TG Therapeutics made up 0.18% of EMFO LLC's portfolio in Q2 2024, its #90 holding.
EMFO LLC first reported a position in TG Therapeutics in Q2 2021 and has held it in 13 quarters since.
EMFO LLC's TG Therapeutics position peaked at $562K in Q2 2021.
259 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.